InMed Pharmaceuticals Inc. Common Shares
Symbol: INM (NASDAQ)
2.22
▲ (1.37%) 0.030
Company Description:
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
Key Stats
- Today's Open: $2.19
- Today's High: $2.265
- Today's Low: $2.176
- Today's Volume: 30.50K
- Yesterday Close: $2.19
- Yesterday High: $2.27
- Yesterday Low: $2.1681
- Yesterday Volume: 80.15K
- Last Min Volume: 10
- Last Min High: $2.22
- Last Min Low: $2.22
- Last Min VWAP: $2.22
Company Profile
- Name: InMed Pharmaceuticals Inc. Common Shares
- Website: https://www.inmedpharma.com
- Listed Date: 2020-11-10
- Location: VANCOUVER, A1
- Market Status: Active
- CIK Number: 0001728328
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $5.22M
- Round Lot: 100
- Outstanding Shares: 2.38M
- Asset Type: CS
RECENT FILINGS FOR INM
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-23 | 8-K | View |
| 2025-09-23 | 8-K | View |
| 2025-09-23 | 10-K | View |
| 2025-09-08 | 8-K | View |
| 2025-08-05 | 424B3 | View |
| 2025-08-01 | EFFECT | View |
| 2025-08-01 | S-1/A | View |
| 2025-07-31 | CORRESP | View |
| 2025-07-28 | 8-K | View |
| 2025-07-14 | CORRESP | View |
| 2025-07-14 | UPLOAD | View |
| 2025-07-09 | S-1 | View |
| 2025-06-30 | 8-K | View |
| 2025-06-24 | 8-K | View |
| 2025-06-13 | 8-K | View |
| 2025-05-29 | DEFA14A | View |
| 2025-05-16 | DEF 14A | View |
| 2025-05-13 | 8-K | View |
| 2025-05-12 | 10-Q | View |
| 2025-04-29 | PRE 14A | View |
Latest News on INM